Foundation Program Sites

Treatment for Opioid Use Disorder (OUD) Revision

Read our 2017 Treatment for OUD Report Here.

Join our conversation

In person

If you are unable to join with the below options, there will be a physical space reserved in the Foundation for Health Care Quality’s Seattle office to participate in the virtual meeting at the below address:

705 2nd Ave
Suite 410
Seattle, WA 98104

Starting in July 2024, our in-person space will be held at:
Industrious 400U @ Rainier Square
400 University Street
Room 3A
Seattle, WA 98101


Teams Meeting Link.
Meeting ID: 250 936 576 146
Passcode: rNjNpL


Opioid use disorder continues to be prevalent in Washington State, with a 10% increase from 2018 to 2019 and 35% for both 2020 and 2021 over the prior year. The Bree Collaborative developed guidelines in 2017, outlining full or partial opioid agonists for treatment (as opposed to treatment without medication). As the number of opioid overdose death rate has continued to climb, the Bree Collaborative members decided to revisit the previous guidelines and report. In the time since the last report, the X waiver requirement has been removed, and the increase in fentanyl in Washington’s drug supply has complicated opioid overdose response. A significant number of methamphetamine overdoses involve opioids, and most people who use drugs use multiple substances. According to the Washington DOH, the stimulant-related overdose death rate has increased 388%. As a result, the response to opioid use and overdose should address strategies that are associated with many drugs not just opioids. Fentanyl and analogues carry a higher overdose risk than other opioids; in 2022, a survey by the UW’s Addiction, Drug & Alcohol Institute (ADAI) found that 18% of respondents had used fentanyl within the past 3 months. There is a need for guidance for providers to improve confidence and competence and for payors on successful and safe initiation, stabilization, and titration of individuals on medication for opioid use disorder in the age of fentanyl with a focus on populations that are or have been underserved.

Next Meeting Time Materials
June 18th, 2024 3-430pm Please see below.

Past Meeting Materials

Date Materials
January 16th, 2024

January Agenda

Draft Charter and Roster

February 20th February Agenda
January Minutes
Draft Focus Areas
March 19th March Agenda
February Minutes
Draft Focus Areas/2017 Report
April 16th April Agenda
March Minutes
Focus Areas
May 21st May Agenda
April Minutes
June 18th June Agenda
May Minutes
July 16th July Agenda
June Minutes
August 20th August Agenda
July Minutes
September 17th September Agenda
August Minutes
October 15th October Agenda
September Minutes
November 19th November Agenda
October Minutes
December 17th December Agenda
November Minutes
January 21st January Agenda
December Minutes

Read our Charter.

Workgroup Members

Name Title Organization
Charissa Fotinos, MD (Chair) Deputy Chief Medical Officer Washington HealthCare Authority
Nikki Jones, LCISW, SUDP, CMHS, DDMHS, GMGS Behavioral Health Addictions Administrator United Health Community
Michael Sayre, MD Medical Director Medic One
Brad Finegood, MA, LMHC Strategic Advisor Opioids and Health King County
Everett Maroon, MPH Executive Director Blue Mountain Heart 2 Heart
Tina Seery, RN, MHA, CPHQ, CPPS, CLSSBB Senior Director, Quality and Rural Programs Washington State Hospital Association
Tawnya Christiansen, MD Behavioral Health Medical Director Community Health Plan of Washington
Sue Petersohn, EN, MBA, CARN Program Manager, Multicare SUD Task Force MultiCare
Mark Murphy, MD Medical Director Addiction Services MultiCare
Libby Hein, LMHC Director of Behavioral Health Molina Healthcare
Ryan Caldeiro, MD Chief Chemical Dependency Services
and Consultative Psychiatry
Kaiser Permanente
Herbie Duber, MD Regional Medical Officer – Northwest WA Department of Health
Bob Lutz, MD, MPH   CHAS Health
Amanda McPeak, PharmD Pharmacist and Director of Long-term Care Kelley-Ross/Harborview
Jason Fodeman, MD Associate Medical Director of Innovation and Outreach L&I
Maureen Oscadal, RN, CARN Registered Nurse Harborview Medical Center/Addiction Drugs and Alcohol Institute
John Olson, MD, MHA Addiction Medicine Physician Sound Health
Daniel Floyd Care Coordination and Recovery Section Manager King County Behavioral Health and Recovery Division
Kelly Youngberg, MHA Assistant Director for Health Care Implementation and Strategy Addictions, Drug and Alcohol Institute
Cris DuVall, PharmD, SUDP, WSPA Clinical Pharmacist Counselor Compass Health, Island Drug
Tom Hutch, MD, FASAM Medical Director We Care Daily Clinic
Liz Wolkin, MSN, RN, NPD-BC CEN Emergency Department Support Program Administrator Washington HealthCare Authority
David Sapienza, MD Lead Physician Pathways, Public Health Seattle & King County – Community Health Services Division